Tracked deals
552
552 tracked deals across 2011-2026.
Tracked deals
552
552 tracked deals across 2011-2026.
Buyer mix
Mixed buyer set
450 strategic · 257 pe
Top trend
Volume peaked in 2022
124 tracked deals announced in 2022.
Primary Insight
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| HCAP Partners | 7 | Southern California-based private equity and mezzanine de... | PE |
| The Stepping Stones Group | 7 | National provider of therapeutic, behavioral, autism, nur... | Strategic (PE-backed) |
| Akeso Occupational Health | 6 | Operator of occupational medicine clinic groups focused o... | Strategic (PE-backed) |
| NMS Capital | 5 | New York-headquartered private investment firm focused on... | PE |
| Spine & Sport Physical Therapy | 5 | Operator of outpatient physical therapy clinics in Southe... | Strategic (PE-backed) |
| Agile Occupational Medicine | 4 | Operator of occupational medicine clinics focused on work... | Strategic |
| Great Point Partners | 4 | Healthcare-focused private equity firm that provides grow... | PE |
| Gryphon Investors | 4 | Middle-market private investment firm focused on growth i... | PE |
| Headlands Research | 4 | Globally integrated clinical trial site organization oper... | Strategic (PE-backed) |
| Levine Leichtman Capital Partners | 4 | Middle-market private equity firm investing across franch... | PE |
Last 10 years
Supporting Data
Headlands Research acquired Clinical Trials Research (CTR), a privately owned clinical research organization with sites in Sacramento and Lincoln, California. The acquired sites will operate as Headlands Research – Sacramento and Headlands Research – CTR Lincoln, expanding Headlands’ California footprint and strengthening its cardiometabolic therapeutic area capabilities. Financial terms were not disclosed.
Micro Imaging Technology (MIT), a California-based public company, announced its acquisition of Cellmyx to expand its regenerative medicine and medical aesthetics portfolio. The deal combines Cellmyx’s autologous adipose grafting and transfer technologies (IntelliFat BOD) with MIT’s recently acquired SaltMed/SaltFacial to broaden manufacturing capabilities and product offerings for orthopedic, plastic, and cosmetic surgery use cases.
Photocure ASA announced the acquisition of Vesica Health, a U.S. precision diagnostics company developing AssureMDx, a urine-based molecular test for early detection of bladder cancer. The transaction is valued at $30.5 million (cash and stock), including a $3.0 million equity investment made in Q1 2026, and includes additional milestone-based consideration tied to Medicare reimbursement and regulatory achievements.
Discovery Behavioral Health (DBH) entered a major restructuring after defaulting on roughly $280 million of debt, following a dispute over its debt-to-earnings calculations. Lenders led by HPS Investment Partners and Capital One seized control, ousting the board and CEO and effectively converting debt into ownership, with a new CEO (Pete Clarke) introduced in the subsequent announcement.
The Radoff-JEC Group (led by Bradley L. Radoff and Michael Torok) issued an open letter urging Seer, Inc. to reevaluate its rejected acquisition proposal and to initiate a strategic review process. The group reaffirms a fully financed proposal to acquire Seer for $2.40 per share in cash (a 42% premium to the unaffected share price) plus a contingent value right (CVR) that would provide stockholders with 80% of the net proceeds from certain asset dispositions.
Liminatus Pharma has entered into a definitive merger agreement to acquire InnocsAI via a newly formed wholly owned Delaware subsidiary. The deal values InnocsAI at approximately $320 million, with InnocsAI’s members receiving 1.6 billion Liminatus shares at $0.20 per share plus contingent value rights (CVRs) tied to 20% of future net proceeds from certain strategic transactions involving the acquired assets.
InSphero AG announced it has acquired PhenoVista Biosciences, Inc., a San Diego-based contract research organization specializing in high-content imaging and phenotypic assay technologies. The deal is intended to expand InSphero’s advanced 3D, cell-based assay and imaging capabilities and accelerate adoption of more predictive, human-relevant drug discovery and toxicology workflows.
Ethos, a claims investigation and medical management firm, acquired Definiti Comp Solutions, a national provider of workers' compensation medical cost containment services. The deal is intended to strengthen Ethos' national bill review capabilities and broaden cost containment solutions for carriers, TPAs, self-insured employers, and public sector clients.
NeuroVision Imaging Inc. acquired Durin Life Sciences Inc. to create an integrated platform for earlier detection and longitudinal management of neurodegenerative diseases. The deal combines Durin’s blood-based biomarker diagnostics (Duritect) with NeuroVision’s retinal imaging, telehealth infrastructure, and BrainHealth.net patient engagement ecosystem.
Medit, a digital dentistry company, has completed the acquisition of Progressive Orthodontics through its U.S. subsidiary Medit USA Inc. The deal also launches Medit’s Global Orthodontic Business Division to combine Medit’s digital orthodontic software and 3D scanning technology with Progressive Orthodontics’ clinical education network.
Treble Health, a telehealth-focused tinnitus and audiology provider, acquired Silicon Valley Hearing, a medical-model audiology practice in Los Gatos, California. The deal expands Treble Health’s in-person services to the San Francisco Bay Area by adding Silicon Valley Hearing’s clinical team and establishing a Los Gatos care location.
Tot Squad announced it is acquiring Robyn, an AI-powered maternal health startup that acts as an always-on doula trained on de-identified conversations between doulas and parents. Robyn will be integrated into Tot Squad’s platform, alongside its registry-based support offerings and marketplace for in-person doula and related services.
LEO Pharma has entered into a definitive agreement to acquire Replay, a gene therapy company developing treatments for rare genetic dermatological conditions. The acquisition adds Replay’s high-payload herpes simplex virus (HSV) delivery vector platform to LEO Pharma’s dermatology pipeline, with the lead program targeting dystrophic epidermolysis bullosa (DEB) currently in preclinical studies.
Nationwide Medical, a provider of specialized respiratory care and home health solutions, announced the acquisition of Dynamic Healthcare Services (DHS). The deal is intended to expand Nationwide Medical’s home respiratory and sleep therapy support and broaden its regional footprint in Pennsylvania, New Jersey, and surrounding markets.
LEEF Brands, Inc. entered into an agreement to acquire Standard Holdings, Inc., the parent company of HIMALAYA Vapor, a California-based cannabis concentrates brand. The deal is valued at approximately US$2.5 million, consisting of 13,688,000 LEEF common shares (including management incentive shares) plus warrants with an aggregate value of US$100,000.
TriNet completed its previously disclosed acquisition of Cocoon, a leave management technology company, and Cocoon became a wholly owned subsidiary of TriNet. The acquisition strengthens TriNet’s leave of absence offering with compliance-first solutions and AI-enabled workflows for SMB employers and their employees.
Neurocrine Biosciences entered into a definitive agreement to acquire Soleno Therapeutics in an all-cash transaction valued at approximately $2.9 billion. The deal adds Soleno’s first-in-class therapy VYKAT XR (diazoxide choline) for hyperphagia in Prader-Willi syndrome to Neurocrine’s commercial portfolio, and is expected to close within 90 days subject to customary conditions and regulatory approvals.
APM Group, a global provider of health and human services, announced that it has joined with occupational health provider WorkCare. The acquisition brings together the companies’ shared commitments to improving outcomes through integrated workforce health solutions, with WorkCare continuing to operate with its existing teams and service delivery approach.
MedReview, a payment integrity solutions provider for health insurers, announced its acquisition of Vital Data Technology. Vital Data will operate as a wholly-owned subsidiary, adding its AI-driven payer workflow and member outcome-focused analytics platform (Affinitē) to MedReview’s payer solution suite.
Collectly, an AI-powered patient financial experience platform for healthcare providers, acquired Pledge Health, an AI automation company focused on pre-service patient financial workflows. The deal adds an AI workflow engine to automate high-friction tasks such as coverage verification, cost estimates, financial clearance, and payment setup within Collectly’s end-to-end platform.
Reveam announced the acquisition of AcceleRAD Technologies, a global supplier of high-performance accelerator systems. The deal will make AcceleRAD a wholly owned subsidiary and expand Reveam’s engineering/manufacturing capabilities to scale its Electronic Cold-Pasteurization (ECP) food safety technology and extend accelerator applications into new industrial sectors.
MedImpact Holdings, Inc. announced the acquisition of two employer insurance and risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions. The deals expand MedImpact’s portfolio of modular care and coverage options for small and mid-sized employers by adding captive program formation and medical stop-loss capabilities.
Gyre Therapeutics has completed its acquisition of Cullgen Inc. in an all-stock transaction valued at approximately $300 million. The deal creates a fully integrated U.S.- and China-based biopharmaceutical company focused on fibrosis and inflammatory diseases, combining Gyre’s commercial asset ETUARY with Cullgen’s targeted protein degrader (TPD) and degrader-antibody conjugate (DAC) platform and pipeline.
Complete Genomics, a U.S.-based genomic sequencing technology company, entered into a definitive agreement to be acquired by Switzerland-based life sciences group Swiss Rockets AG. The deal is expected to scale Complete Genomics’ innovation pipeline and expand/diversify manufacturing capacity, while maintaining continuity for customers and Complete Genomics’ U.S.-based operations and software support.
Gilead Sciences entered into a definitive agreement to acquire Arcellx for $115 per share in cash plus a $5 per share contingent value right, implying an equity value of about $7.8 billion. The deal was completed on April 27, 2026, with Arcellx becoming a wholly owned subsidiary and full control of anito-cel and Arcellx’s D-Domain CAR technology platform.
Danaher entered into a definitive agreement to acquire Masimo, paying $180 per share in cash for all outstanding shares, valuing the transaction at approximately $9.9 billion. Danaher is acquiring Masimo to expand its Diagnostics segment with pulse oximetry and AI-enabled patient monitoring solutions focused on acute care settings.
Paradigm, a specialty care management organization focused on complex injuries and diagnoses, has entered into a definitive agreement to be acquired by Patient Square Capital. The transaction is expected to close in the first half of 2026, marking the conclusion of Paradigm’s partnership with OMERS Private Equity.
Ear Professionals Group has acquired Soundly, a digital hearing solutions platform, to integrate Soundly’s consumer-facing resources and private-label brand into its provider network beginning March 2026. The acquisition is intended to streamline the patient journey from online research to in-clinic prescription fittings and expand Ear Professionals Group’s direct-to-consumer reach.
GCM, a precision outsourced manufacturer focused on MedTech, has acquired Kettmann Machining, a supplier of precision-machined plastic and metal parts for MedTech customers. The deal adds a 40,000-square-foot manufacturing facility in San Jose, California, aimed at expanding capacity and high-precision capabilities for next-generation medical devices.
Nautic Partners has completed a growth investment in KabaFusion, a national provider of home and alternative-site infusion services. KabaFusion’s clinician-led management team remains significant investors and will continue to lead the company while Novo Holdings exited its investment; the capital will support accelerated growth and expanded access to infusion care nationwide.
NOCD — now operating under the AI-enabled parent brand Noto — has acquired Rebound Health, a self-help trauma recovery platform focused on PTSD. The acquisition brings Rebound onto Noto's platform to scale virtual specialty therapy for trauma disorders nationwide, leveraging NOCD/Noto's therapist network, payer partnerships, and AI-enabled operations.
Golden State Dermatology (GSD), a physician-owned dermatology platform with 45 locations and more than 125 providers, has acquired NorCal Vein Specialists, a two-location vein care practice operating in Pleasanton and Sacramento, California. The deal brings vein-focused medical and cosmetic services onto GSD's platform to deepen clinical capabilities and offer a more integrated patient experience while maintaining the practice's existing physician, staff, locations, and operations.
HCAP Partners completed a follow-on, add-on acquisition for its Integrated Diagnostic Services (IDS) platform with the purchase of Core Analytics Lab & Radiology, a provider of mobile radiology and laboratory services across California. The deal expands IDS' footprint into Northern California, adds in-house mobile laboratory diagnostics to its bundled service offering for skilled nursing, long-term care, and home health providers, and increases statewide route density and service integration.
St. Cloud Capital made a growth capital investment in Integrated Diagnostic Services (IDS) to support IDS’ acquisition of Core Analytics Lab & Radiology, a provider of mobile radiology and laboratory services in California. The financing round included participation from HCAP Partners, Southfield Mezzanine, and California Bank & Trust and is intended to expand IDS’ in‑house lab capabilities, improve route density, and increase responsiveness to patients in post‑acute settings.
OpenAI has acquired Torch, a small health-records startup, in a deal reported at about $100 million. The four-person team from Torch will join OpenAI to help build out its ChatGPT Health capabilities by aggregating and normalizing fragmented patient data.
AVS Life Sciences acquired ValidPath, a biotech quality engineering leader focused on CQV (commissioning, qualification, and validation) services for life sciences manufacturers. The acquisition expands AVS’s end-to-end quality, regulatory, and engineering capabilities across pharmaceutical, biotech, medical device, and diagnostic industries.
Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a 503A compounding pharmacy based in California and focused on health and wellness. The deal, announced in September 2025, strengthens Fagron’s U.S. footprint—particularly in California—and supports its strategy to build a nationwide platform spanning both 503A and 503B services.
Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a California-based 503A pharmaceutical compounder focused on the health and wellness segment. The deal, initially announced in September 2025, closed following customary clearance and reinforces Fagron’s strategy to build a nationwide U.S. compounding platform spanning both 503A and 503B services.
Skylight Health has acquired Stellation Care, a provider analytics company, to integrate AI-powered provider and network intelligence into its multispecialty orchestration platform. The deal (terms undisclosed) is intended to enhance Skylight's Illuminations analytics and referral-optimization capabilities for health plans and risk-bearing provider groups.
PAI Pharma, an Olympus Partners portfolio company, acquired Nivagen Pharmaceuticals to expand domestic aseptic sterile injectable manufacturing capacity and accelerate development of ready-to-use (RTU) injectable products for hospitals. The deal adds a newly built state-of-the-art aseptic facility in Sacramento, California, and brings a pipeline of more than 20 RTU sterile injectable products.
IntelyCare has acquired CareRev in an add-on deal to create a comprehensive workforce staffing platform spanning acute and post-acute care; financial terms were not disclosed. The combined organization will integrate clinician-facing job boards, recruiter/sourcing tools, contingent labor resources and internal resource pool capabilities while both brands continue operating separately.
Pentec Health, a specialty pharmacy and infusion services provider, has acquired Hartley Medical Center Pharmacy, a Long Beach, California-based compounding pharmacy specializing in sterile intrathecal medications for implanted pump therapy. Hartley will continue operating from its Long Beach 503A pharmacy with owner William Stuart remaining as General Manager; the deal expands Pentec's intrathecal sterile compounding capabilities and integrates pharmacy services with Pentec's nursing and administrative support.
SBC Medical Group Holdings (Nasdaq: SBC) has made a strategic minority investment and formed an alliance with OrangeTwist to support clinical, operational, and technology integration as OrangeTwist expands its footprint. In conjunction with the deal, OrangeTwist acquired six additional med spa locations in Colorado and Nevada, bringing the platform to 24 locations across six states; OrangeTwist is backed by PE firms Hildred and Athyrium Capital Management.
Day One Biopharmaceuticals acquired Mersana Therapeutics in a deal announced as a tender offer for all outstanding shares at $25 per share in cash plus a contingent value right (CVR) per share for potential milestone payments. The acquisition adds Mersana’s clinical-stage ADC emiltatug ledadotin (Emi-Le) targeting adenoid cystic carcinoma (ACC) to Day One’s oncology pipeline.
ProSites, a Rockbridge Growth Equity-backed platform, has acquired GeniusVets, a veterinary marketing and client-engagement platform. The acquisition folds GeniusVets into ProSites' LifeLearn brand to expand AI-enabled marketing, client communication, and education tools for veterinary practices nationwide.
Enjoin, a 3 Boomerang Capital portfolio company, has acquired Pediatric Resource Group (PRG), a pediatric-focused clinical documentation integrity (CDI) and physician advisory firm. The add-on expands Enjoin’s DRG assurance and revenue integrity capabilities to include pediatric and neonatal APR-DRG expertise for children’s hospitals and health systems nationwide.
GoSaga, the wellness and fitness holding company founded by Geoff Schneider, acquired Squeeze Massage, a 14-unit massage and wellness franchisor, in November. GoSaga plans to rebuild the franchisor infrastructure, restart franchise sales in 2026, and leverage shared services to scale the brand within its fitness and wellness portfolio.
Mosaic Clinical Technologies, the technology and AI services division of Radiology Partners, has acquired Cognita Imaging Inc., a radiology-focused AI company that emerged from stealth. The acquisition integrates Cognita's vision-language foundation models into MosaicOS to expand diagnostic capacity, improve accuracy and accelerate deployment of AI-powered radiology tools across Radiology Partners' national network.
Unio Specialty Care, part of the Unio Health Partners platform, announced a partnership to integrate Comprehensive GI Care of Los Alamitos, California into its statewide gastroenterology platform. The affiliation expands Unio's presence in Southern California and aims to improve access to advanced GI procedures, care coordination and screening programs; terms were not disclosed.
Emergence, an enterprise backed by The Pritzker Organization, has acquired MedEvolve, an AI-powered revenue cycle automation and analytics provider. The acquisition combines MedEvolve’s Effective Intelligence platform with Emergence’s software expertise and long-term capital to accelerate AI-driven capabilities for healthcare revenue cycle management.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
They include acquisitions across primary care technology, precision diagnostics, contract research and imaging tools, claims investigation and medical cost containment, telehealth and specialty clinical practices, and other condition-focused healthcare services.
Examples from the page include Elation Health, Photocure ASA, InSphero AG, Ethos, NeuroVision Imaging, Medit, Treble Health, Tot Squad, LEO Pharma, and Nationwide Medical.
Both. Several acquisitions describe strengthening AI/diagnostic or imaging capabilities, while others emphasize expanding care delivery capacity such as telehealth services and clinical practice coverage.
Yes. The page also features an acquisition related to cannabis concentrates branding via LEEF Brands, Inc. and Standard Holdings, Inc. (parent of HIMALAYA Vapor), which is adjacent to healthcare services in the broader health ecosystem.